Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 20;2(1):e000382.
doi: 10.1136/bmjmed-2022-000382. eCollection 2023.

Post-viral olfactory loss and parosmia

Affiliations
Review

Post-viral olfactory loss and parosmia

Zhen Yu Liu et al. BMJ Med. .

Abstract

The emergence of SARS-CoV-2 has brought olfactory dysfunction to the forefront of public awareness, because up to half of infected individuals could develop olfactory dysfunction. Loss of smell-which can be partial or total-in itself is debilitating, but the distortion of sense of smell (parosmia) that can occur as a consequence of a viral upper respiratory tract infection (either alongside a reduction in sense of smell or as a solo symptom) can be very distressing for patients. Incidence of olfactory loss after SARS-CoV-2 infection has been estimated by meta-analysis to be around 50%, with more than one in three who will subsequently report parosmia. While early loss of sense of smell is thought to be due to infection of the supporting cells of the olfactory epithelium, the underlying mechanisms of persistant loss and parosmia remain less clear. Depletion of olfactory sensory neurones, chronic inflammatory infiltrates, and downregulation of receptor expression are thought to contribute. There are few effective therapeutic options, so support and olfactory training are essential. Further research is required before strong recommendations can be made to support treatment with steroids, supplements, or interventions applied topically or injected into the olfactory epithelium in terms of improving recovery of quantitative olfactory function. It is not yet known whether these treatments will also achieve comparable improvements in parosmia. This article aims to contextualise parosmia in the setting of post-viral olfactory dysfunction, explore some of the putative molecular mechanisms, and review some of the treatment options available.

Keywords: epidemiology; pathology, surgical; pharmacology, clinical; physiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: We have read and understood the BMJ policy on declaration of interests and declare the following interests: none.

Figures

Figure 1
Figure 1
Putative mechanisms of post-viral olfactory dysfunction. CSF=cerebrospinal fluid
Figure 2
Figure 2
Potential mechanisms of parosmia. (A) Normal arrangement of olfactory neuroepithelium and its central projections; this image shows the bipolar olfactory sensory neurons, supported by sustenacular cells, and basal cells. (B) Viral induced disruption of the neuroepithelium, with loss of olfactory sensory neurons, sustenacular cells, and basal cells. (C) In the so-called miswiring hypothesis of parosmia, aberrant neural regeneration leads to formation of random and incorrect axonal connection. (D) In the hypothesis of incomplete neural regeneration of parosmia, whereby correct axonal regeneration occurs but only for selected receptor types, leading to incomplete characterisation and misclassification of an odour owing to failure to detect all odour molecular components

Similar articles

Cited by

References

    1. Frasnelli J, Landis BN, Heilmann S, et al. . Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol 2004;261:411–5. 10.1007/s00405-003-0703-y - DOI - PubMed
    1. Pellegrino R, Mainland JD, Kelly CE, et al. . Prevalence and correlates of parosmia and phantosmia among smell disorders. Chem Senses 2021;46:bjab046. 10.1093/chemse/bjab046 - DOI - PMC - PubMed
    1. Henkin RI, Larson AL, Powell RD. Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection. Ann Otol Rhinol Laryngol 1975;84:672–82. 10.1177/000348947508400519 - DOI - PubMed
    1. Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am 2004;37:1159–66. 10.1016/j.otc.2004.06.007 - DOI - PubMed
    1. Cain WS, Gent JF, Goodspeed RB, et al. . Evaluation of olfactory dysfunction in the Connecticut chemosensory clinical research center. Laryngoscope 1988;98:83–8. 10.1288/00005537-198801000-00017 - DOI - PubMed